<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>KLF6, a ubiquitously expressed Krüppel-like transcription factor, is frequently inactivated in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and has significant roles in cellular proliferation, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, differentiation and development </plain></SENT>
<SENT sid="1" pm="."><plain>A key mechanism of KLF6-mediated growth suppression is through p53-independent transactivation of p21 </plain></SENT>
<SENT sid="2" pm="."><plain>Several <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-derived KLF6 mutants lead to the loss of p21-mediated growth suppression through an unknown mechanism </plain></SENT>
<SENT sid="3" pm="."><plain>Because several <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and <z:hpo ids='HP_0001402'>hepatocellular carcinoma</z:hpo>-derived KLF6 mutations affect a <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase kinase 3β (GSK3β) phosphorylation consensus site, we investigated the role of GSK3β in the regulation of KLF6 function </plain></SENT>
<SENT sid="4" pm="."><plain>Based on transient transfection, GSK3β augments the transactivation of a p21 promoter luciferase by KLF6 </plain></SENT>
<SENT sid="5" pm="."><plain>Reciprocal co-immunoprecipitation of hemagglutinin (HA)-GSK3β and Flag-KLF6 validated the interaction between these two proteins </plain></SENT>
<SENT sid="6" pm="."><plain>KLF6 phosphorylation is augmented in the presence of GSK3β based on in vitro and in vivo (32)P incorporation assays </plain></SENT>
<SENT sid="7" pm="."><plain>Site-directed mutagenesis of the candidate phosphorylation sites to alanines ('KLF6-4A' phosphomutant) eliminated a higher molecular weight phosphorylated isoform of KLF6 based on western blot </plain></SENT>
<SENT sid="8" pm="."><plain>GSK3β augmented the transactivation by <z:mp ids='MP_0002169'>wild-type</z:mp> KLF6, but not KLF6-4A, towards the p21 promoter, and increased p21 protein </plain></SENT>
<SENT sid="9" pm="."><plain>Functionally, GSK3β enhanced KLF6-mediated growth suppression, which was abrogated by the KLF6-4A phosphomutant </plain></SENT>
<SENT sid="10" pm="."><plain>These data establish that GSK3β directly phosphorylates KLF6, which augments its induction of p21 and resultant growth suppression </plain></SENT>
<SENT sid="11" pm="."><plain>This interaction may account for the growth-promoting effects of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-derived KLF6 mutants that lack <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor activity.Oncogene advance online publication, 22 October 2012; doi:10.1038/onc.2012.457 </plain></SENT>
</text></document>